1. Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
- Author
-
Stéphane Raffard, Sophie Bayard, Margot Eisenblaetter, Philippe Tattard, Jérôme Attal, Yasmine Laraki, Delphine Capdevielle, Dynamique des capacités humaines et des conduites de santé (EPSYLON), Université Paul-Valéry - Montpellier 3 (UPVM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Fondation FondaMental [Créteil], Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), and Guerineau, Nathalie C.
- Subjects
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Capacity to consent to treatment ,[SDV]Life Sciences [q-bio] ,Healthcare ,COVID-19 ,General Medicine ,[SDV] Life Sciences [q-bio] ,Psychiatry and Mental health ,Schizophrenia ,Pharmacology (medical) ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Vaccine ,Biological Psychiatry ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccination was assessed in 80 outpatients with schizophrenia. Using the MacArthur Competence Assessment Tool for Treatment, 56.3% of the sample were classified as having diminished capacity to consent to the vaccination. Diminished capacity to consent to COVID-19 vaccination was associated with lower vaccination rates, poorer cognition and higher level of psychotic symptoms. Developing interventions for enhancing informed consent for vaccination is urgent within this population.
- Published
- 2022
- Full Text
- View/download PDF